文献速递慢性肾脏病

慢性肾脏病及肾衰竭患者对大麻使用的看法:一项调查研究

Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

该调查纳入320名加拿大成年肾脏病患者,评估其对大麻用于焦虑、抑郁、不宁腿、瘙痒、疲劳、慢性疼痛、食欲下降、恶心呕吐、睡眠、痉挛等症状管理的意愿。超过50%的受访者对全部10种症状可能或肯定会尝试大麻;既往大麻使用、在线受访及症状类型(疼痛、睡眠、不宁腿)与尝试意愿独立相关。

要点

  • 50.2%(160/320)受访者曾使用大麻,最常见原因依次为娱乐(52.5%)、缓解疼痛(39.4%)和改善睡眠(35.0%)。
  • 仅33.8%的既往使用者认为医生知晓其大麻使用情况。
  • 超过50%的受访者对全部10种症状可能或肯定会尝试大麻进行症状控制。

核心结论

  • 许多肾脏病患者使用大麻,且对尝试大麻进行症状控制存在兴趣。

研究设计与样本

  • 针对加拿大成年肾脏病患者的调查研究,共纳入320名受访者,其中290名(90.6%)来自现场招募(应答率27.3%),30名(9.4%)来自在线招募。
  • 采用改良Likert量表(1分=肯定不会,5分=肯定会)评估受访者对每种症状考虑使用大麻的程度。
  • 采用多水平多变量线性回归分析识别与考虑使用大麻控制症状相关的受访者特征。

主要发现

  • 160/320名受访者(50.2%)曾使用大麻,包括吸烟140例(87.5%)、油剂69例(43.1%)和食用92例(57.5%)。
  • 既往使用大麻最常见的原因依次为娱乐84/160例(52.5%)、缓解疼痛63/160例(39.4%)和改善睡眠56/160例(35.0%)。
  • 仅33.8%的既往大麻使用者认为其医生知晓其大麻使用情况。
  • 超过50%的受访者对全部10种症状可能或肯定会尝试大麻进行症状控制。
  • 与尝试大麻控制症状意愿独立相关的特征包括症状类型(疼痛、睡眠、不宁腿)、在线受访者(β=0.7,95%CI 0.1-1.4)和既往大麻使用(β=1.2,95%CI 0.9-1.5)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cannabis is frequently used recreationally and medicinally, including for symptom management in patients with kidney disease. METHODS: We elicited the views of Canadian adults with kidney disease regarding their cannabis use. Participants were asked whether they would try cannabis for anxiety, depression, restless legs, itchiness, fatigue, chronic pain, decreased appetite, nausea/vomiting, sleep, cramps and other symptoms. The degree to which respondents considered cannabis for each symptom was assessed with a modified Likert scale ranging from 1 to 5 (1, definitely would not; 5, definitely would). Multilevel multivariable linear regression was used to identify respondent characteristics associated with considering cannabis for symptom control. RESULTS: Of 320 respondents, 290 (90.6%) were from in-person recruitment (27.3% response rate) and 30 (9.4%) responses were from online recruitment. A total of 160/320 respondents (50.2%) had previously used cannabis, including smoking [140 (87.5%)], oils [69 (43.1%)] and edibles [92 (57.5%)]. The most common reasons for previous cannabis use were recreation [84/160 (52.5%)], pain alleviation [63/160 (39.4%)] and sleep enhancement [56/160 (35.0%)]. Only 33.8% of previous cannabis users thought their physicians were aware of their cannabis use. More than 50% of respondents probably would or definitely would try cannabis for symptom control for all 10 symptoms. Characteristics independently associated with interest in trying cannabis for symptom control included symptom type (pain, sleep, restless legs), online respondent {β = 0.7 [95% confidence interval (CI) 0.1-1.4]} and previous cannabis use [β = 1.2 (95% CI 0.9-1.5)]. CONCLUSIONS: Many patients with kidney disease use cannabis and there is interest in trying cannabis for symptom control.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Collister D, Herrington G, Delgado L, et al. Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study. Nephrol Dial Transplant. 2023. PMID: 35881478. doi:10.1093/ndt/gfac226

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。